Skip to content

Understanding the Side Effects of Antileukotriene Medications

3 min read

In 2020, the FDA issued a boxed warning for montelukast, a common antileukotriene, highlighting the potential for serious neuropsychiatric side effects, including suicidal thoughts and actions. This class of medication, which also includes zafirlukast and zileuton, is used to manage asthma and allergies by blocking inflammatory leukotrienes.

Quick Summary

Antileukotriene medications can cause a range of adverse reactions, from common gastrointestinal issues and headaches to rare but serious neuropsychiatric events, liver problems, and allergic reactions. Specific drug profiles differ, necessitating patient and caregiver vigilance for any concerning symptoms. Close monitoring by a healthcare provider is essential during treatment.

Key Points

  • Neuropsychiatric Risk: Antileukotriene medications, especially montelukast, carry a boxed warning for serious mental health side effects including agitation, depression, anxiety, and suicidal thoughts or behavior.

  • Liver Damage: Zafirlukast and zileuton are associated with a risk of hepatotoxicity (liver injury), which requires regular monitoring of liver function.

  • Churg-Strauss Syndrome: A rare but serious inflammatory disorder of blood vessels can occur, particularly when oral steroid doses are reduced.

  • Common Side Effects: Mild side effects are frequent and include headaches, gastrointestinal upset, and flu-like symptoms.

  • Immediate Medical Attention: Seek immediate help for severe allergic reactions (anaphylaxis, angioedema) or signs of liver problems (jaundice, dark urine).

  • Ongoing Monitoring: Patients and caregivers should closely monitor for any behavioral or mood changes and report them to a healthcare provider promptly.

In This Article

Antileukotrienes are a class of medications designed to manage chronic inflammatory conditions such as asthma and allergic rhinitis (allergies). They work by blocking the action of leukotrienes, inflammatory substances that cause airway muscle contraction and mucus production. While effective for many, it is crucial to understand the full spectrum of potential side effects of antileukotriene drugs, which can range from mild to severe and, in rare cases, life-threatening.

Common and Mild Side Effects

Many patients who take antileukotrienes will experience only mild side effects, which may diminish over time. These issues are often non-specific and are frequently managed without medical intervention.

  • Gastrointestinal issues: Stomach pain, nausea, vomiting, and diarrhea are commonly reported.
  • Headaches: Headaches are among the most frequently observed side effects.
  • Flu-like symptoms: Some individuals may experience fever, sore throat, or a general feeling of malaise.
  • Upper respiratory tract infections: These can manifest as a cough, sinusitis, or a runny/stuffy nose.
  • Fatigue: Feelings of unusual tiredness or weakness have been noted in some patients.

Serious and Neuropsychiatric Side Effects

A more significant concern for all antileukotriene medications, particularly montelukast, is the risk of serious neuropsychiatric events. The U.S. Food and Drug Administration (FDA) has placed a boxed warning on montelukast to alert patients and healthcare providers to this risk. Patients and caregivers should be vigilant for any changes in mood or behavior.

  • Psychiatric symptoms: These can include anxiety, agitation, aggression, hostility, depression, irritability, and restlessness.
  • Sleep disturbances: Insomnia, abnormal or vivid dreams, nightmares, and sleepwalking (somnambulism) have been reported.
  • Cognitive issues: Patients may experience attention problems, memory impairment, confusion, or disorientation.
  • Suicidal ideation: In rare cases, suicidal thoughts and behaviors have been reported in patients taking montelukast.
  • Hallucinations and tremor: Very rarely, hallucinations (seeing or hearing things that aren't there) and tremors have been reported.

Rare but Potentially Life-Threatening Side Effects

Hepatotoxicity (Liver Damage)

This is a recognized risk, especially with zileuton and zafirlukast, though rare. Symptoms of liver problems include:

  • Persistent nausea and vomiting
  • Loss of appetite
  • Pain in the upper right abdomen
  • Dark urine or pale stools
  • Jaundice (yellowing of the skin or eyes)

Churg-Strauss Syndrome

Known medically as Eosinophilic Granulomatosis with Polyangiitis (EGPA), this is a rare but severe autoimmune disease that can affect blood vessels. It has been reported in patients taking antileukotrienes, especially during a dose reduction or withdrawal of oral steroids. Signs to watch for include:

  • Flu-like symptoms, rash, and worsening asthma
  • Pins and needles or numbness in the limbs
  • Pain and swelling of the sinuses

Severe Hypersensitivity Reactions

While less common, some patients may experience severe allergic reactions. These include:

  • Anaphylaxis: A life-threatening allergic reaction.
  • Angioedema: Swelling of the face, lips, tongue, or throat.
  • Severe skin reactions: Blistering, peeling, or widespread rash.

Antileukotriene Side Effect Comparison

Feature Montelukast (Singulair) Zafirlukast (Accolate) Zileuton (Zyflo)
Common Side Effects Headache, stomach pain, flu-like symptoms, cough, diarrhea Headache, abdominal pain, nausea, diarrhea Headache, nausea, muscle pain, nose/throat irritation
Neuropsychiatric Risk FDA Boxed Warning; agitation, depression, anxiety, suicidal thoughts Documented; anxiety, depression, insomnia, suicidal thoughts Documented; agitation, depression, anxiety, suicidal thoughts
Hepatotoxicity Risk Uncommon, but documented cases Higher risk, requires monitoring Higher risk, requires monitoring
Drug Interactions Minimal; less affected by food Can increase levels of other drugs like theophylline and warfarin Can increase levels of other drugs like theophylline and propranolol

What to Do If You Experience Side Effects

If you or a loved one experiences any new or concerning symptoms while taking an antileukotriene, it is crucial to act promptly. For severe or life-threatening reactions, seek immediate medical attention. For other symptoms, contact your healthcare provider to discuss the best course of action. Do not stop taking the medication abruptly without a doctor's guidance, as this could worsen the underlying condition. Your doctor may need to adjust your medication or switch to an alternative therapy. Reporting serious adverse reactions to regulatory agencies like the FDA can also help with ongoing safety monitoring.

Conclusion

While antileukotrienes are valuable tools for managing chronic respiratory conditions, they are not without risk. The potential for serious neuropsychiatric side effects, especially with montelukast, as well as the risk of liver damage with zafirlukast and zileuton, underscores the need for careful patient selection and continuous monitoring. Patients and their families should be fully informed about these risks and empowered to communicate any unusual symptoms to their healthcare team. A thorough discussion of benefits versus risks is essential for all individuals considering or currently taking antileukotriene medication.(https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug)

Frequently Asked Questions

The most serious side effect of antileukotriene medications, particularly montelukast, is the risk of neuropsychiatric events, which can include serious mood and behavior changes, depression, and suicidal thoughts or actions.

Yes, some antileukotrienes, specifically zafirlukast and zileuton, carry a risk of liver damage (hepatotoxicity). Symptoms like jaundice, dark urine, or abdominal pain should be reported to a doctor immediately.

If you or your caregiver notice new or worsening neuropsychiatric symptoms, you should stop the medication and contact your doctor immediately. Abruptly stopping without medical advice is not recommended, but these symptoms warrant prompt medical review.

Neuropsychiatric reactions have been reported in all age groups taking montelukast, but certain symptoms like aggression, nightmares, and behavior changes are more frequently reported in the pediatric population.

Churg-Strauss Syndrome is a rare, severe blood vessel disease reported in patients on antileukotriene medication, sometimes triggered when oral steroid doses are reduced. Symptoms include flu-like illness, numbness, and rash.

Mild side effects like headache, stomach pain, and flu-like symptoms are relatively common and often lessen or disappear after the first few weeks of treatment.

Montelukast is most known for neuropsychiatric side effects (and has an FDA boxed warning), while zafirlukast and zileuton carry a higher risk of hepatotoxicity and require liver function monitoring. All three share some common, milder side effects.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.